Literature DB >> 20204471

Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates.

Vasco Filipe1, Andrea Hawe, Wim Jiskoot.   

Abstract

PURPOSE: To evaluate the nanoparticle tracking analysis (NTA) technique, compare it with dynamic light scattering (DLS) and test its performance in characterizing drug delivery nanoparticles and protein aggregates.
METHODS: Standard polystyrene beads of sizes ranging from 60 to 1,000 nm and physical mixtures thereof were analyzed with NTA and DLS. The influence of different ratios of particle populations was tested. Drug delivery nanoparticles and protein aggregates were analyzed by NTA and DLS. Live monitoring of heat-induced protein aggregation was performed with NTA.
RESULTS: NTA was shown to accurately analyze the size distribution of monodisperse and polydisperse samples. Sample visualization and individual particle tracking are features that enable a thorough size distribution analysis. The presence of small amounts of large (1,000 nm) particles generally does not compromise the accuracy of NTA measurements, and a broad range of population ratios can easily be detected and accurately sized. NTA proved to be suitable to characterize drug delivery nanoparticles and protein aggregates, complementing DLS. Live monitoring of heat-induced protein aggregation provides information about aggregation kinetics and size of submicron aggregates.
CONCLUSION: NTA is a powerful characterization technique that complements DLS and is particularly valuable for analyzing polydisperse nanosized particles and protein aggregates.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20204471      PMCID: PMC2852530          DOI: 10.1007/s11095-010-0073-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

Review 1.  Bioequivalence and the immunogenicity of biopharmaceuticals.

Authors:  Huub Schellekens
Journal:  Nat Rev Drug Discov       Date:  2002-06       Impact factor: 84.694

2.  Induction and analysis of aggregates in a liquid IgG1-antibody formulation.

Authors:  Hanns-Christian Mahler; Robert Müller; Wolfgang Friess; Aurelie Delille; Susanne Matheus
Journal:  Eur J Pharm Biopharm       Date:  2005-04       Impact factor: 5.571

Review 3.  Protein drug stability: a formulation challenge.

Authors:  Sven Frokjaer; Daniel E Otzen
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

4.  Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation.

Authors:  Patrick H Brown; Peter Schuck
Journal:  Biophys J       Date:  2006-03-24       Impact factor: 4.033

Review 5.  Protein aggregation and bioprocessing.

Authors:  Mary E M Cromwell; Eric Hilario; Fred Jacobson
Journal:  AAPS J       Date:  2006-09-15       Impact factor: 4.009

Review 6.  Immunological risk of injectable drug delivery systems.

Authors:  Wim Jiskoot; Rianne M F van Schie; Myrra G Carstens; Huub Schellekens
Journal:  Pharm Res       Date:  2009-02-27       Impact factor: 4.200

Review 7.  A critical review of methods for size characterization of non-particulate protein aggregates.

Authors:  John S Philo
Journal:  Curr Pharm Biotechnol       Date:  2009-06       Impact factor: 2.837

8.  Insulin association in neutral solutions studied by light scattering.

Authors:  S Hvidt
Journal:  Biophys Chem       Date:  1991-02       Impact factor: 2.352

9.  Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality.

Authors:  John F Carpenter; Theodore W Randolph; Wim Jiskoot; Daan J A Crommelin; C Russell Middaugh; Gerhard Winter; Ying-Xin Fan; Susan Kirshner; Daniela Verthelyi; Steven Kozlowski; Kathleen A Clouse; Patrick G Swann; Amy Rosenberg; Barry Cherney
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

10.  Response of a concentrated monoclonal antibody formulation to high shear.

Authors:  Jared S Bee; Jennifer L Stevenson; Bhavya Mehta; Juraj Svitel; Joey Pollastrini; Robert Platz; Erwin Freund; John F Carpenter; Theodore W Randolph
Journal:  Biotechnol Bioeng       Date:  2009-08-01       Impact factor: 4.530

View more
  322 in total

1.  Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry.

Authors:  Els J van der Vlist; Esther N M Nolte-'t Hoen; Willem Stoorvogel; Ger J A Arkesteijn; Marca H M Wauben
Journal:  Nat Protoc       Date:  2012-06-14       Impact factor: 13.491

2.  Characterization of a nanoparticulate drug delivery system using scanning ion occlusion sensing.

Authors:  Lin Yang; Murray F Broom; Ian G Tucker
Journal:  Pharm Res       Date:  2012-05-26       Impact factor: 4.200

Review 3.  Systematic review of factors influencing extracellular vesicle yield from cell cultures.

Authors:  Johann Mar Gudbergsson; Kasper Bendix Johnsen; Martin Najbjerg Skov; Meg Duroux
Journal:  Cytotechnology       Date:  2015-10-03       Impact factor: 2.058

4.  Holographic Characterization of Protein Aggregates.

Authors:  Chen Wang; Xiao Zhong; David B Ruffner; Alexandra Stutt; Laura A Philips; Michael D Ward; David G Grier
Journal:  J Pharm Sci       Date:  2016-02-02       Impact factor: 3.534

5.  Multimodal Dispersion of Nanoparticles: A Comprehensive Evaluation of Size Distribution with 9 Size Measurement Methods.

Authors:  Fanny Varenne; Ali Makky; Mireille Gaucher-Delmas; Frédéric Violleau; Christine Vauthier
Journal:  Pharm Res       Date:  2016-02-10       Impact factor: 4.200

6.  Coordinated Regulation of Intracellular Fascin Distribution Governs Tumor Microvesicle Release and Invasive Cell Capacity.

Authors:  James W Clancy; Christopher J Tricarico; Daniel R Marous; Crislyn D'Souza-Schorey
Journal:  Mol Cell Biol       Date:  2019-01-16       Impact factor: 4.272

7.  Platelet factor 4 is a biomarker for lymphatic-promoted disorders.

Authors:  Wanshu Ma; Hyea Jin Gil; Noelia Escobedo; Alberto Benito-Martín; Pilar Ximénez-Embún; Javier Muñoz; Héctor Peinado; Stanley G Rockson; Guillermo Oliver
Journal:  JCI Insight       Date:  2020-07-09

8.  Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.

Authors:  Wei-hui Liu; Li-na Ren; Xing Wang; Tao Wang; Ning Zhang; Yuan Gao; Hao Luo; Nalu Navarro-Alvarez; Li-jun Tang
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-28       Impact factor: 4.553

Review 9.  Protein particulate detection issues in biotherapeutics development--current status.

Authors:  Tapan K Das
Journal:  AAPS PharmSciTech       Date:  2012-05-08       Impact factor: 3.246

Review 10.  Nanoparticle counting: towards accurate determination of the molar concentration.

Authors:  Jing Shang; Xiaohu Gao
Journal:  Chem Soc Rev       Date:  2014-08-07       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.